HDT BIO CORP
Federal contract awards won by HDT BIO CORP (UEI Z33DCMWXZBK7), 2019–2023 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
4
awards
$13,818,109
total value
1
agency
Agencies buying from HDT BIO CORP
What HDT BIO CORP sells
Awards
HDT BIO CORP - AOI #21 VACCINE ON DEMAND: R&D USE OF LION-REPRNA IN RAPID RESPONSE VACCINE DEVELOPMENT
Department of Health and Human Services · $749,000 · Sep 22, 2023
ADAPTABLE RNA-BASED ANTIBODY PLATFORM FOR PROTECTION AGAINST CONTEMPORARY/EMERGING HUMAN ENTEROVIRUSES
Department of Health and Human Services · $1,499,422 · Jul 1, 2022
COVID-19. TO DEVELOP AND PROGRESS HDT-301, A REPLICON RNA ENCODING SARS-COV-2 SPIKE PROTEIN BOUND TO LIPID INORGANIC NANOPARTICLE (LION) FORMULATION TO PROTECT AGAINST COVID-19, THROUGH A PHASE I CLINICAL TRIAL.
Department of Health and Human Services · $10,970,058 · Sep 1, 2020
RATIONAL DEVELOPMENT OF A COMBINATION NANOPARTICLE ADJUVANT FOR INFLUENZA.
Department of Health and Human Services · $599,629 · Sep 1, 2019
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids